47
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

FORCED EXPRESSION OF BCL-2 AND BCL-xL BY NOVEL WATER-SOLUBLE FULLERENE, C60(GLUCOSAMINE)6, REDUCES RENAL ISCHEMIA/REPERFUSION-INDUCED OXIDATIVE STRESS

, , , &
Pages 77-88 | Received 15 May 2000, Published online: 06 Feb 2007
 

Abstract

Apoptosis induced by oxidative stress, especially reactive oxygen species, resulting from ischemia/reperfusion would lead to organ dysfunction. C60(glucosamine)6, a water-soluble fullerene with strong free radical scavenging activity, was applied to evaluate its effect on renal ischemia/reperfusion-induced apoptosis formation and superoxide generation. C60(glucosamine)6 pretreatment, but not posttreatment, significantly reduced renal ischemia/reperfusion-induced apoptosis and superoxide generation and, consequently, ameliorated renal hemodynamic effects. Up-regulation in bcl-2 and bcl-xL of the rat kidney was evident in C60(glucosamine)6 pretreated, posttreated, and nontreated groups. However, exaggerated forced expression of bcl-2 and bcl-xL was found in the C60(glucosamine)6 pretreated group. Our results conclude that forced expression of bcl-2 and bcl-xL by the novel water-soluble fullerene, C60(glucosamine)6, can reduce renal ischemia/ reperfusion-induced oxidative stress.

ACKNOWLEDGMENT

This work was supported by the National Science Council of the Republic of China (NSC89-2314-B002-119 and NSC89-2314-B002-148) and partly by the National Taiwan University Hospital (NTUH89A014).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.